While battling its COVID-19 crisis, India struggles with a ‘Black Fungus’ epidemic
FirstpostPM Modi described the fungal disease as a new “challenge” and said it was “important to create systems to tackle it.” In the stifling, tightly packed medical ward at Civil Hospital, the ear, nose and throat specialist moved briskly from one bed to the next, shining a flashlight into one patient’s mouth, examining another’s X-rays. Unprepared for this spring’s devastating COVID-19 second wave, many of India’s hospitals took desperate steps to save lives — steps that may have opened the door to yet another deadly disease. Many doctors prescribed steroids in quantities and for durations that far exceed World Health Organization recommendations, said Arunaloke Chakrabarti, a microbiologist and co-author of a study examining the causes of India’s mucormycosis outbreak. “That’s a very painful choice,” said Dr Atul Patel, an infectious diseases specialist at the private Sterling Hospital in Ahmedabad who has treated dozens of mucormycosis patients in the outbreak.